These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6363565)

  • 41. An open study of ceftazidime in the treatment of serious bacterial infection.
    Allan SG; Glover SC; Smith CC; Hadley KM; Reid TM; Han K; Murdoch JM; Ingram PM
    J Antimicrob Chemother; 1983 Sep; 12(3):219-27. PubMed ID: 6355044
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Cefotaxime in the treatment of purulent meningitis in children (author's transl)].
    Borderon JC; Despert F; Santini JJ; Laugier J; Grenier B; Boulard P
    Nouv Presse Med; 1981 Feb; 10(8):634-8. PubMed ID: 6259609
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ceftazidime treatment in intensive care patients.
    van Dalen R; Muytjens HL; Gimbrère JS
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():189-97. PubMed ID: 6225763
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ceftazidime therapy for serious infections.
    Bint AJ; Constable J; Patton KR; Constable FL
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():115-21. PubMed ID: 6352613
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ceftazidime - a significant advance in the treatment of cystic fibrosis.
    David TJ; Phillips BM; Connor PJ
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():337-40. PubMed ID: 6352639
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Spontaneous bacterial peritonitis caused by Pseudomonas aeruginosa].
    Montalvo II; Gil I; Arriola JA; Arenas JI
    Gastroenterol Hepatol; 1996 Nov; 19(9):489. PubMed ID: 8998675
    [No Abstract]   [Full Text] [Related]  

  • 47. Therapeutic efficacy of intravitreal ceftazidime, imipenem, and amikacin in a swine model of posttraumatic Pseudomonas aeruginosa endophthalmitis.
    Ng EW; D'Amico DT
    Retina; 1997; 17(5):464-5. PubMed ID: 9355203
    [No Abstract]   [Full Text] [Related]  

  • 48. Ceftazidime treatment of chronic Pseudomonas aeruginosa respiratory tract infection in cystic fibrosis.
    Permin H; Koch C; Høiby N; Christensen HO; Møller AF; Møller S
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():313-23. PubMed ID: 6352636
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Postantibiotic effect of carbapenems against Pseudomonas aeruginosa.
    Hikida M; Yamazaki Y; Yoshida M; Kawashima K; Nishiki K; Mitsuhashi S
    J Antibiot (Tokyo); 1995 Aug; 48(8):891-2. PubMed ID: 7592037
    [No Abstract]   [Full Text] [Related]  

  • 50. Ceftazidime in cystic fibrosis: clinical, microbiological and immunological studies.
    Cullen RT; McCrae WM; Govan J; Raeburn JA; Ingram TM
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():369-75. PubMed ID: 6352647
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical studies on ceftazidime in surgery in Japan.
    Nakayama I
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():377-81. PubMed ID: 6352648
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ceftazidime alone and in combination in patients with cystic fibrosis: lack of efficacy in treatment of severe respiratory infections caused by Pseudomonas cepacia.
    Gold R; Jin E; Levison H; Isles A; Fleming PC
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():331-6. PubMed ID: 6352638
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alternative antibiotics for the treatment of Pseudomonas infections in cystic fibrosis.
    Mastella G; Agostini M; Barlocco G; Bonomi U; Borgo G; Bozzino L; Cabrini G; Cappelletti LM; Castellani L; Conforti M
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():297-311. PubMed ID: 6311788
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [New cephalosporin with favorable pharmacokinetic properties].
    Gabler-Sandberger E
    MMW Munch Med Wochenschr; 1983 Sep; 125(35):75-6. PubMed ID: 6415426
    [No Abstract]   [Full Text] [Related]  

  • 55. In vitro properties of ceftazidime, a highly active broad-spectrum cephalosporin with antipseudomonal activity.
    Harper PB
    Clin Ther; 1984; 6(4):411-24. PubMed ID: 6432324
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum bactericidal activity of ceftazidime administered as continuous infusion of 3 g over 24 h versus intermittent bolus infusion of 2 g against Pseudomonas aeruginosa in healthy volunteers.
    Lemmen SW; Engels I; Daschner FD
    J Antimicrob Chemother; 1997 Jun; 39(6):841-2. PubMed ID: 9222063
    [No Abstract]   [Full Text] [Related]  

  • 57. Filamented Pseudomonas aeruginosa and a markedly high level of endotoxin in cerebrospinal fluid.
    Kawano C; Muroi K; Yozhizawa M; Kirikae T; Ozawa K
    J Infect; 2000 Jul; 41(1):114-5. PubMed ID: 10942652
    [No Abstract]   [Full Text] [Related]  

  • 58. In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa.
    Bui KQ; Banevicius MA; Nightingale CH; Quintiliani R; Nicolau DP
    J Antimicrob Chemother; 2000 Jan; 45(1):57-62. PubMed ID: 10629013
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical results and pharmacokinetics of ceftazidime treatment in patients with cystic fibrosis.
    Strandvik B; Malmborg AS; Alfredson H; Ericsson A
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():283-7. PubMed ID: 6352633
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Therapeutic effects of cefozopran against experimental mixed urinary tract infection with Enterococcus faecalis and Pseudomonas aeruginosa in mice.
    Tsuchimori N; Yamazaki T; Okonogi K
    J Antimicrob Chemother; 1997 Mar; 39(3):423-5. PubMed ID: 9096195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.